Our study integrates the miRNA and proteome data with GWAS genes or genes implicated with hypertension and HPO annotations, which provide a powerful framework for understanding both the beneficial and adverse effects of antihypertensive drugs at the molecular level. This evidence concerns the gene GFER and Hypertension.